Literature DB >> 11083547

Simplified quantitative determination of cerebral perfusion reserve with H2(15)O PET and acetazolamide.

M Arigoni1, S Kneifel, J Fandino, N Khan, C Burger, A Buck.   

Abstract

The measurement of regional cerebral blood flow (rCBF) and perfusion reserve (PR) with H2(15)O positron emission tomography (PET) and acetazolamide challenge is of importance in evaluating patients with cerebrovascular disease and is thought to be useful in selecting patients for possible vascular surgery. Full quantitative assessment of rCBF with PET requires arterial blood sampling, which is inconvenient in a clinical setting. In this work, we present a simple non-invasive method with which to quantitatively evaluate PR in one PET session lasting no more than 30 min. In ten patients with cerebrovascular disease, rCBF was measured with H2(15)O PET under the baseline condition and after administration of 1 g acetazolamide using a standard technique involving arterial blood sampling. The activity accumulated over 60 s was normalized to injected activity per kilogram body weight (nAA) and compared with rCBF in eight different brain regions. A high linear correlation was found for PR based on nAA (PRnAA) and rCBF (PRrCBF) (PRnAA=0.843 PRrCBF + 0.092, r=-0.83, Pearson's correlation coefficient). Bland-Altman analyses further confirmed that PRnAA reflects PR in a quantitative manner. These results demonstrate that the method based on normalized counts allows the quantitative assessment of PR without blood sampling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083547     DOI: 10.1007/s002590000319

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  3 in total

1.  Quantitative cerebral H2(15)O perfusion PET without arterial blood sampling, a method based on washout rate.

Authors:  Valerie Treyer; Mathieu Jobin; Cyrill Burger; Vincenzo Teneggi; Alfred Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-28       Impact factor: 9.236

2.  Hypercapnic BOLD MRI compared to H215O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease.

Authors:  Till-Karsten Hauser; Achim Seeger; Benjamin Bender; Uwe Klose; Johannes Thurow; Ulrike Ernemann; Marcos Tatagiba; Philipp T Meyer; Nadia Khan; Constantin Roder
Journal:  Neuroimage Clin       Date:  2019-02-04       Impact factor: 4.881

3.  Hemodynamic evaluation of patients with Moyamoya Angiopathy: comparison of resting-state fMRI to breath-hold fMRI and [15O]water PET.

Authors:  Leonie Zerweck; Constantin Roder; Till-Karsten Hauser; Johannes Thurow; Annerose Mengel; Marcos Tatagiba; Nadia Khan; Philipp T Meyer; Ulrike Ernemann; Uwe Klose
Journal:  Neuroradiology       Date:  2021-09-27       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.